FEL-33885-80471
3 vaccinations
2 coded responses
10 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 277 / NC
- Registered
- 2021-12-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Dose 1 — Pfizer-BioNTech
-
2021-04-14
Dose 2 — Pfizer-BioNTech
-
2021-12-08
Registered in v-safe
-
2021-12-08
Dose 3 — Pfizer-BioNTech
- 2021-12-08
-
2021-12-09
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-12-11
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Swelling · Fatigue or tirednessAdult check-in
- 2021-12-12
- 2021-12-14
-
2021-12-15
Health check-in — day 7, dose 3Feeling: Fair · Headache · Be unable to work or attend schoolAdult check-in
- 2021-12-22
-
2021-12-29
Survey response — day 21, dose 3MedDRA: Chills, Diarrhoea, Fatigue, Hypotension, Syncope — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diarrhea, low blood pressure, chills, faintness, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2021-12-29
Report sent to call center — day 21, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-03
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-01-09
-
2022-01-19
Survey response — day 42, dose 3MedDRA: Nasal congestion, Oropharyngeal pain, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend schoolFree text: Sore throat, chest congestion, nasal congestionMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | No |
| 2 | 2021-04-14 | Pfizer-BioNTech | No |
| 3 | 2021-12-08 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 10 — day 21, dose 3
Symptoms: Diarrhea, low blood pressure, chills, faintness, fatigue
Release 10 — day 42, dose 3
Symptoms: Sore throat, chest congestion, nasal congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hypotension | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Syncope | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release